Literature DB >> 3796830

31P NMR studies in Duchenne muscular dystrophy: age-related metabolic changes.

D P Younkin, P Berman, J Sladky, C Chee, W Bank, B Chance.   

Abstract

To evaluate possible progressive metabolic changes in Duchenne muscular dystrophy, we used 31P nuclear magnetic resonance spectroscopy to measure high-energy phosphate compounds and phosphorylated diesters (PDE) in resting gastrocnemius muscle of 14 Duchenne patients and 10 normal boys. The patients had higher inorganic phosphate (Pi), intracellular pH, and PDE; and lower phosphocreatine (PCr) and PCr/Pi ratio; ATP was not significantly different. The patients showed significant age-related decreases in PCr and PCr/Pi, and increases in Pi and PDE, but ATP did not change. In normal boys, ATP increased with age, but PCr and Pi did not. These studies imply progressive metabolic deterioration in Duchenne dystrophy.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3796830     DOI: 10.1212/wnl.37.1.165

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  28 in total

1.  31P-MRS of skeletal muscle is not a sensitive diagnostic test for mitochondrial myopathy.

Authors:  Tina Dysgaard Jeppesen; Bjørn Quistorff; Flemming Wibrand; John Vissing
Journal:  J Neurol       Date:  2007-02-04       Impact factor: 4.849

2.  Fatigability, Exercise Intolerance, and Abnormal Skeletal Muscle Energetics in Heart Failure.

Authors:  Kilian Weiss; Michael Schär; Gurusher S Panjrath; Yi Zhang; Kavita Sharma; Paul A Bottomley; Asieh Golozar; Angela Steinberg; Gary Gerstenblith; Stuart D Russell; Robert G Weiss
Journal:  Circ Heart Fail       Date:  2017-07       Impact factor: 8.790

3.  Early metabolic changes measured by 1H MRS in healthy and dystrophic muscle after injury.

Authors:  Su Xu; Stephen J P Pratt; Espen E Spangenburg; Richard M Lovering
Journal:  J Appl Physiol (1985)       Date:  2012-06-28

4.  A novel glycerophosphodiester phosphodiesterase, GDE5, controls skeletal muscle development via a non-enzymatic mechanism.

Authors:  Yuri Okazaki; Noriyasu Ohshima; Ikumi Yoshizawa; Yasutomi Kamei; Stefania Mariggiò; Keiko Okamoto; Masahiro Maeda; Yoshihito Nogusa; Yuichiro Fujioka; Takashi Izumi; Yoshihiro Ogawa; Yoshitsugu Shiro; Masanobu Wada; Norihisa Kato; Daniela Corda; Noriyuki Yanaka
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

5.  Longitudinal metabolomic analysis of plasma enables modeling disease progression in Duchenne muscular dystrophy mouse models.

Authors:  Roula Tsonaka; Mirko Signorelli; Ekrem Sabir; Alexandre Seyer; Kristina Hettne; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Hum Mol Genet       Date:  2020-03-27       Impact factor: 6.150

Review 6.  Mechanisms of resistance to pathogenesis in muscular dystrophies.

Authors:  J P Infante; V A Huszagh
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 7.  Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials.

Authors:  Pierre G Carlier; Benjamin Marty; Olivier Scheidegger; Paulo Loureiro de Sousa; Pierre-Yves Baudin; Eduard Snezhko; Dmitry Vlodavets
Journal:  J Neuromuscul Dis       Date:  2016-03-03

Review 8.  Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications.

Authors:  Hee Kyung Kim; Diana M Lindquist; Suraj D Serai; Yogesh K Mariappan; Lily L Wang; Arnold C Merrow; Kiaran P McGee; Richard L Ehman; Tal Laor
Journal:  Radiol Clin North Am       Date:  2013-07       Impact factor: 2.303

9.  Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study.

Authors:  Martin Torriani; Elise Townsend; Bijoy J Thomas; Miriam A Bredella; Reza H Ghomi; Brian S Tseng
Journal:  Skeletal Radiol       Date:  2011-07-29       Impact factor: 2.199

10.  Decreased rates of Ca(2+)-dependent heat production in slow- and fast-twitch muscles from the dystrophic (mdx) mouse.

Authors:  A Decrouy; P C Even; A Chinet
Journal:  Experientia       Date:  1993-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.